BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 38057406)

  • 1. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.
    Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
    Cancer Immunol Immunother; 2021 Apr; 70(4):1015-1029. PubMed ID: 33104837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression.
    Nie F; Zhang J; Tian H; Zhao J; Gong P; Wang H; Wang S; Yang P; Yang C
    Cell Death Dis; 2024 Apr; 15(4):277. PubMed ID: 38637499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma.
    Xiao M; Zhang J; Chen W; Chen W
    J Exp Clin Cancer Res; 2018 Jul; 37(1):143. PubMed ID: 29986759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FERMT2 upregulation in CAFs enhances EMT of OSCC and M2 macrophage polarization.
    Ma X; Zhao D; Liu S; Zuo J; Wang W; Wang F; Li Y; Ding Z; Wang J; Wang X
    Oral Dis; 2024 Apr; 30(3):991-1003. PubMed ID: 37357349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the effect of CCR7 on the microenvironment of mouse oral squamous cell carcinoma by single-cell RNA sequencing technology.
    Wang Z; Kirkwood KL; Wang Y; Du W; Lin S; Zhou W; Yan C; Gao J; Li Z; Sun C; Liu F
    J Exp Clin Cancer Res; 2024 Mar; 43(1):94. PubMed ID: 38539232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
    Prgomet Z; Axelsson L; Lindberg P; Andersson T
    J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of activating transcription factor 6 (ATF6) as a novel prognostic biomarker and potential target in oral squamous cell carcinoma.
    Wu Y; Xie Q; Wu L; Li Z; Li X; Zhang L; Zhang B
    Gene; 2024 Jul; 915():148436. PubMed ID: 38579904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevotella intermedia boosts OSCC progression through ISG15 upregulation: a new target for intervention.
    Qin Y; Li Z; Liu T; Ma J; Liu H; Zhou Y; Wang S; Zhang L; Peng Q; Ye P; Duan N; Wang W; Wang X
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):206. PubMed ID: 38644421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARγ Antagonists Exhibit Antitumor Effects by Regulating Ferroptosis and Disulfidptosis.
    Zhang S; Wang Y; Gu J; Yang Y; Liang J; Wang Y; Ji N; Liu M; Zhang Y; Sun S; Chen Q; Li J
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38786003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between cancer cells and macrophages promotes OSCC cell migration and invasion through a CXCL1/EGF positive feedback loop.
    Huang W; Jiang M; Lin Y; Qi Y; Li B
    Discov Oncol; 2024 May; 15(1):145. PubMed ID: 38713320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma.
    Shie WY; Cheng SJ; Chen KC; Tang CC; Peng HH; Ko HH; Hou HH; Elizabeth Chou HY
    J Formos Med Assoc; 2024 Mar; 123(3):390-399. PubMed ID: 37704482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of innate lymphoid cells in oral squamous cell carcinoma microenvironment].
    Liu LP; Zha Y; Wang JY; Xu LY; Qin X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2024 Apr; 59(4):394-399. PubMed ID: 38548598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-killed Prevotella intermedia promotes the progression of oral squamous cell carcinoma by inhibiting the expression of tumor suppressors and affecting the tumor microenvironment.
    Zhou Y; Qin Y; Ma J; Li Z; Heng W; Zhang L; Liu H; Li R; Zhang M; Peng Q; Ye P; Duan N; Liu T; Wang W; Wang X
    Exp Hematol Oncol; 2024 Mar; 13(1):33. PubMed ID: 38515216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction to "HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization".
    Cancer Med; 2024 May; 13(9):e7205. PubMed ID: 38715541
    [No Abstract]   [Full Text] [Related]  

  • 15. Correction to: OSCC cell‑secreted exosomal CMTM6 induced M2‑like macrophages polarization via ERK1/2 signaling pathway.
    Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
    Cancer Immunol Immunother; 2022 Feb; 71(2):505-506. PubMed ID: 34821952
    [No Abstract]   [Full Text] [Related]  

  • 16. Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization.
    Guo H; Shu J; Hu G; Liu B; Li J; Sun J; Wang X; Liu H; Xiong S; Tang Y; Yin Y; Wang X
    PLoS One; 2024; 19(5):e0302780. PubMed ID: 38713738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
    Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
    Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
    Cai J; Qiao B; Gao N; Lin N; He W
    Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.